[Research progress of microRNAs in sepsis-associated acute kidney injury]

Area of Science:

• Nephrology
• Critical Care Medicine
• Infectious Diseases

Background:

• Sepsis is a life-threatening condition characterized by organ dysfunction due to an imbalanced host response to infection.
• Sepsis-associated acute kidney injury (SA-AKI) is a frequent and severe complication of sepsis, associated with poor prognosis and high mortality rates.
• The complex pathogenesis of SA-AKI remains incompletely understood, highlighting the need for further research.

Purpose of the Study:

• To emphasize the critical need for effective biomarkers in the early diagnosis of SA-AKI.
• To highlight the importance of biomarkers for monitoring disease progression and predicting prognosis in SA-AKI patients.
• To underscore the urgency of identifying novel diagnostic and prognostic tools for SA-AKI within clinical practice.

Main Methods:

• This study focuses on the clinical and pathophysiological aspects of SA-AKI.
• Literature review and analysis of current research on SA-AKI pathogenesis and biomarkers.
• Discussion of the challenges in diagnosing and managing SA-AKI.

Main Results:

• SA-AKI is a significant contributor to overall mortality in sepsis patients.
• Current understanding of SA-AKI pathogenesis is limited, hindering effective treatment strategies.
• The lack of validated biomarkers impedes timely diagnosis and personalized management.

Conclusions:

• There is an urgent clinical need for the development and validation of biomarkers for SA-AKI.
• Effective biomarkers are essential for early detection, treatment guidance, and prognosis assessment of SA-AKI.
• Advancing the understanding of SA-AKI pathogenesis is key to discovering novel therapeutic targets and improving patient survival.